JHVEPhoto CVS Health (NYSE:CVS) has launched a new subsidiary dedicated to marketing biosimilars in the US, with Sandoz’s version of…
Browsing: humira
Organon launches biosimilar of AbbVie's Humira Source link
vzphotos After generating $208B in sales over two decades, AbbVie’s (NYSE:ABBV) monopoly over its world’s bestselling therapy Humira (adalimumab) is…
Alvotech, Bioventure get approval for Humira biosimilar in Saudi Arabia Source link
JHVEPhoto Although AbbVie’s blockbuster treatment Humira (adalimumab) will see biosimilar competition this year, the company expects that Rinvoq (upadacitinib) and…
Biotechnology firm, Amgen, is planning to make its mark first U.S. biosimilar to AbbVie’s megablockbuster Humira. During the 2022 Biotechnology…